Actio Biosciences Announces Initiation of KYRON Phase 1b/2 Trial of ABS-1230 for the Treatment of KCNT1-Related Epilepsy and Acceptance into FDA’s Rare Disease Evidence Principles Process Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel…
SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG Affiliates of funds advised by SK Capital Partners, LP a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today…
Sunnybrook Announces $41-Million Gift to Advance Canada’s Global Leadership in Clinical Trials Sunnybrook Health Sciences Centre is proud to announce a $41M philanthropic investment in Sunnybrook Clinical Trials. The investment expands dedicated infrastructure, capacity and expertise across Sunnybrook to optimize how clinical…
ValGenesis Partners with Westbourne to Expand Digital Validation Services for Life Sciences ValGenesis Inc., the market leader in digital validation lifecycle management, and Westbourne, a life sciences-focused IT services and engineering company, have formed a strategic partnership to expand global…
Litmys and Konovo Form Partnership to Revolutionize Drug Development Intelligence for Life Sciences Companies Litmys, a life sciences commercial strategy consulting firm, specializing in the development of commercial readiness analytics, and Konovo, a technology-first healthcare intelligence company that accelerates access to…
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced…
Trinity Launches InsightsEDGE™ Digital Twins — Generative AI Unlocks Always-On Intelligence for Life Sciences Commercial Teams Trinity today announced broad launch of InsightsEDGE™ | Digital Twins, a market tested AI-solution that creates interactive virtual replicas of HCPs, patients, and payers, grounded…
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Pulse Biosciences, Inc. developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first…
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board Harmony Biosciences Holdings, Inc. announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Directors, including the appointment of Troy…
Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts Clarametyx Biosciences, Inc. a clinical-stage biotechnology company developing immune-enabling therapies and vaccines to address biofilm-driven chronic respiratory disease, today announced two senior leadership positions within its executive team to support…
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right Aurinia Pharmaceuticals Inc. a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs, announced…
Sinopia Biosciences Awarded NCI Grant to Advance LEADS® Drug Discovery Platform for Oncology Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® (LEarn And DiScover) drug discovery platform, today announced it has been awarded a…